(Q44161807)

30 November 2017

Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma (English)

1 reference

30 November 2017

0 references

budesonide/formoterol

1 reference

Tal A

1

1 reference

30 November 2017

Simon G

2

1 reference

30 November 2017

Vermeulen JH

3

1 reference

30 November 2017

Petru V

4

1 reference

30 November 2017

Cobos N

5

1 reference

30 November 2017

Everard ML

6

1 reference

30 November 2017

de Boeck K

7

1 reference

30 November 2017

1 November 2002

1 reference

30 November 2017

Pediatric Pulmonology

1 reference

30 November 2017

34

1 reference

30 November 2017

5

1 reference

30 November 2017

342-350

1 reference

Pediatric asthma disease management

30 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10173

Trends in prevalence and severity of childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10173

Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10173

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10173

Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10173

Cost effectiveness of inhaled corticosteroid plus bronchodilator therapy versus bronchodilator monotherapy in children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10173

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10173

Long-term effects of budesonide or nedocromil in children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10173

Effect of long-term treatment with inhaled budesonide on adult height in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10173

A comparison of the efficacy and safety of inhaled corticosteroids in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10173

Efficacy and safety of inhaled corticosteroids. New developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10173

Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10173

Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10173

Effect of formoterol on clinical parameters and lung functions in patients with bronchial asthma: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10173

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10173

A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10173

21 January 2018

Identifiers

DOI

10.1002/PPUL.10173

1 reference

30 November 2017

1 reference